Medacta Group SA

Swiss Stock Exchange MOVE.SW

Medacta Group SA Operating Cash Flow for the year ending December 31, 2023: USD 82.92 M

Medacta Group SA Operating Cash Flow is USD 82.92 M for the year ending December 31, 2023, a 5.43% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Medacta Group SA Operating Cash Flow for the year ending December 31, 2022 was USD 78.65 M, a 27.80% change year over year.
Medacta Group SA Operating Cash Flow for the year ending December 31, 2021 was USD 61.54 M, a -15.46% change year over year.
Medacta Group SA Operating Cash Flow for the year ending December 31, 2020 was USD 72.80 M, a 52.15% change year over year.
Medacta Group SA Operating Cash Flow for the year ending December 31, 2019 was USD 47.85 M, a -37.05% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Swiss Stock Exchange: MOVE.SW

Medacta Group SA

CEO	Dr. Francesco Siccardi
IPO Date	April 3, 2019
Location	Switzerland
Headquarters	Strada Regina, 34
Employees	1,826
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Robotics

Description

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Key trends

Past 5 years